15-17 November 2016

Paul Bouten attended the Congress Partnerships in Clinical Trials (PCT) where he was moderator, chairperson and panel discussion leader on day 2, November 17^th, 2016.

Day 2, November 17^th, 2016

STREAM 8 - Regulatory, Compliance & RBM -

Moderator and chair

STREAM 7 - Partnership Management –

INTERACTIVE HUB panel discussion: Full Service versus Functional Outsourcing

• Functional vs. full service outsourcing: do you have a strategy or just a jumble of legacy contracts? This session will focus on the strategic drives that will help you develop a coherent sourcing strategy

• The role of standardisation

• Sole providers vs. multiple vendor partner companies

• Multi-national CROs vs. Niche/local providers

Original Thesis Title: De Cliëntenraad, de spil in het geheel

Een theoretisch exploratief onderzoek naar de relatie tussen de organisatiestructuur van de cliëntenraad, kennis en vaardigheden van de cliëntenraadsleden en communicatie tussen bestuur en cliëntenraden gelïeerd aan deze zorgstellingen.

Translation:

The client- council, the integral linchpin

A theoretical exploratory research study into the relationship between the organizational structure of the client-council, knowledge and skills of the client councillors and communications between management and client councils affiliated with the healthcare organization

Published Article thesis on website (Netwerk Cliëntenraden in de Zorg (NCZ) and NCZ-Magazine (http://ncz.nl/thesis-de-clientenraad-de-spil-in-het-geheel/)

16 & 17 February 2016

Paul Bouten attended the Outsourcing in Clinical Trials - Medical Devices Europe 2016 where he was moderator and panel discussion leader on day 1, February 16th 2016

Day 1, February 16th, 2016 

Panel Discussion: - Identifying the balance between in-house and outsourcing operations to find the right fit for your trial-

• Outlining the differences between big and small company perspective to evaluate the benefits of a variety of outsourcing models

• Investigating the growing trend of CROs offering full outsourcing services to determine the impact on manufacturers’ choice to outsource

• Discussing which operations should be outsourced to allow manufacturers to focus on their core-competencies

• Underlining the role of CRAs to examine their impact on outsourced clinical trials

• Evaluating the difference of cost when initiating trials in the US to ascertain which plan is best for your company

17-19 November 2015

Paul Bouten attended the Congress Partnerships in Clinical Trials (PCT) where he was 1 to 1 panel discussion leader on day 2, November 19^th, 2015.

Day 2, November 19^th, 2015

Ask the Expert

Topic: Best practise for request for proposal

4-6 November 2014

Paul Bouten attended the Congress Partnerships in Clinical Trials (PCT) where he was moderator and panel discussion leader on the special focus day, November 4^th, 2014.

Special Focus Day, November 4^th, 2014

STREAM X – Outsourcing Essentials -

Moderator and discussion leader

INTERACTIVE HUB panel discussion

HUB Session 1: Best Practice for bid grids and RFPs (requests for proposals)

• Talking through and analysis draft examples of pharma and CRO bid grids

• Decided whose bid grid is best to use

• Incorporating technical and business requirements

18 & 19 February 2014

Paul Bouten attended the Outsourcing in Clinical Trials - Medical Devices Europe 2014 where he was moderator and panel discussion leader on day 1, February 18^th 2014

Day 1, February 18^th, 2014

Panel Discussion: Performing pre-contract audits to ensure potential vendors will meet your trial requirements

• Investigating skill sets and experiences of the clinical team to qualify they have the appropriate knowledge to carry out your trial

• Encouraging meetings with external staff to evaluate their qualifications and their scientific backgrounds to clarify how much training will need to be provided

• Analysing the quality of potential partners by utilizing referrals from the industry to assess the strength of a vendor

• Developing targeted questionnaires to really understand the vendors’ capabilities to improve effective vendor auditing

• Considering a potential vendor’s network of contacts as an important factor in vendor selection to determine how this can be capitalized upon

• Evaluating the skill set and strengths of the vendor to develop a relationship with complementing capabilities

• Determining the staff turnover at the vendor to ascertain stability of the teams who may be working on the trial